Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
54,790,889
-
Total 13F shares
-
18,553,564
-
Share change
-
+6,511,231
-
Total reported value
-
$265,128,131
-
Put/Call ratio
-
38%
-
Price per share
-
$14.29
-
Number of holders
-
88
-
Value change
-
+$93,669,119
-
Number of buys
-
64
-
Number of sells
-
26
Institutional Holders of Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) as of Q3 2015
As of 30 Sep 2015,
Cara Therapeutics, Inc. - Common Stock, par value $0.001 per share (CARA) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,553,564 shares.
The largest 10 holders included
FMR LLC, RHO CAPITAL PARTNERS INC, Sectoral Asset Management Inc, BlackRock Fund Advisors, MILLENNIUM MANAGEMENT LLC, JENNISON ASSOCIATES LLC, FRANKLIN RESOURCES INC, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, VANGUARD GROUP INC, and EverPoint Asset Management, LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q3 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.